View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Sleep Medicine News

SPONSORED CONTENT
Save
SPONSORED CONTENT
May 26, 2023
1 min read
Save

FDA grants MRI conditional use for implantable sleep apnea therapy

FDA grants MRI conditional use for implantable sleep apnea therapy

The FDA has granted conditional use with MRI to an implantable transvenous phrenic nerve stimulation therapy for adults with moderate to severe central sleep apnea.

SPONSORED CONTENT
May 24, 2023
2 min read
Save

Poor diet adherence, sleep disorders synergistically increases mortality risk

Poor diet adherence, sleep disorders synergistically increases mortality risk

Poor adherence to the Mediterranean diet combined with a presence of sleep disorders jointly increased the risk for all-cause and cardiovascular mortality, a recent study found.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
May 23, 2023
2 min read
Save

Sleep apnea may increase risk for long COVID

Sleep apnea may increase risk for long COVID

People with obstructive sleep apnea, particularly those with other chronic conditions, had a significantly increased risk for developing long COVID after a SARS-CoV-2 infection compared with those without obstructive sleep apnea, data show.

SPONSORED CONTENT
May 22, 2023
1 min read
Save

Q&A: 'Careful medication selection' key when treating depression, anxiety, sleep issues

Q&A: 'Careful medication selection' key when treating depression, anxiety, sleep issues

Zachary A. Cordner, MD, PhD, assistant professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine, spoke with Healio about the relationship between sleep and depression and anxiety.

SPONSORED CONTENT
May 18, 2023
3 min read
Save

Sunosi 'likely superior' treatment for daytime sleepiness in patients with sleep apnea

Sunosi 'likely superior' treatment for daytime sleepiness in patients with sleep apnea

Sunosi, Wakix and armodafinil-modafinil reduced excessive daytime sleepiness in patients with obstructive sleep apnea who are already receiving conventional therapy, with Sunosi being “likely superior,” according to researchers.

SPONSORED CONTENT
May 16, 2023
3 min read
Save

Central sleep apnea linked to worse mortality outcomes than obstructive sleep apnea

Central sleep apnea linked to worse mortality outcomes than obstructive sleep apnea

Compared with obstructive sleep apnea, veterans with central sleep apnea had greater mortality rates, shorter time to death and higher mortality hazard, according to study results published in Annals of the American Thoracic Society.

SPONSORED CONTENT
May 11, 2023
3 min read
Save

Obstructive sleep apnea negatively affects cognition in women with multiple sclerosis

Obstructive sleep apnea negatively affects cognition in women with multiple sclerosis

Obstructive sleep apnea had a significant effect on perceived problems with cognitive function in women with multiple sclerosis, according to study results published in Multiple Sclerosis Journal.

SPONSORED CONTENT
May 05, 2023
2 min read
Save

Transition from daylight saving time to standard time linked to transient sleep disorders

Transition from daylight saving time to standard time linked to transient sleep disorders

The transition to standard time was associated with a transient increase in self-reported sleep disorders, while no problems with sleep were reported after the transition to daylight saving time, according to data in Neurology.

SPONSORED CONTENT
May 04, 2023
2 min read
Save

Combination pramipexole, rasagiline reduced daytime sleepiness in adults with early PD

Combination pramipexole, rasagiline reduced daytime sleepiness in adults with early PD

BOSTON — Treatment with an investigational combination of low-dose pramipexole and rasagiline led to less excessive daytime sleepiness and fewer adverse events compared with pramipexole alone in early Parkinson’s disease, research showed.

SPONSORED CONTENT
May 02, 2023
1 min read
Save

FDA approves Lumryz for cataplexy, excessive daytime sleepiness in adults with narcolepsy

FDA approves Lumryz for cataplexy, excessive daytime sleepiness in adults with narcolepsy

The FDA has approved Lumryz, an extended-release formulation of sodium oxybate for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails